Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: Molecular identification and interaction with vasoactive intestinal peptide (VIP)

Abstract

Molecular identification of the binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) and the effect of vasoactive intestinal peptide (VIP) on the specific binding sites for PACAP in rat cultured astrocyte membrane preparations were investigated. Affinity cross-linking of astrocyte membrane preparations with [ 125I]PACAP27 showed the presence of a 60 kDa radiolabeled ligand-receptor complex. The labeling of this band was completely abolished in the presence of 10 −8 M or higher concentrations of unlabeled PACAP27. The molecular weight of this binding protein was estimated to be 57 kDa assuming an equimolar interaction of ligand and receptor in the 60 kDa complex. The labeling of [ 125I]PACAP27 binding to this binding protein was partly reduced by the addition of 10 −6 M VIP, but not by 10 −8 M. In the binding assay, VIP displaced the specific binding of [ 125I]PACAP27 at 10 −7 M or a greater concentration. Displacement of [ 125I]PACAP27 binding by unlabeled PACAP27 was analyzed in the presence or absence of 10 −6 M VIP. VIP at 10 −6 M reduced the maximal binding capacity (B max) of the high affinity binding site for PACAP27 by about 50% but did not alter the B max of the low affinity binding site. The dissociation constants (K d) for both the high and low affinity binding sites were unaltered. These results indicate that PACAP binds to a 57 kDa membrane protein with high affinity and that VIP, at much higher concentrations, binds to this same binding site, suggesting that VIP mimics the biological action of PACAP in astrocytes at high concentrations.